Tetraphase Pharmaceuticals Announces Pricing of Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/27/2026
- Nasdaq poised to lead Wall St after Nvidia puts AI fears to rest
- Nvidia forecasts 70% sales growth next year, signals AI spending boom has years left to run
- Oil gains as traders weigh prospects of easing Middle East supply disruptions
- Could SpaceX's orbital compute avoid the political headwinds facing data centers?
- Could Meta's teen settlement be less painful than feared? Citi weighs in
- Nutanix (NTNX) Tops Q4 EPS by 11c, Beats in Revenue; Offers Q1 Revenue Guidance
- Boston Scientific discloses cybersecurity incident causing global disruption
- Crude Inventory Rose 0.1 Million Barrels Last Week - EIA
- Wall Street stocks end tad lower after hot inflation data ahead of Nvidia earnings
- Revolution Medicines prices RASONQUE at $39,800 per month
Tetraphase Pharma (TTPH) Prices Larger 4.3M Common Offering at $35/Share
March 12, 2015 8:55 AM EDTTetraphase Pharma (NASDAQ: TTPH) announced the pricing of an underwritten public offering of 4,300,000 shares of common stock for a public offering price of $35.00 per share. The gross proceeds to Tetraphase from this offering are expected to be approximately $150.0 million, before deducting underwriting discounts and... More
